Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05310279 · ClinicalTrials.gov registry record · NA

Feasibility of An Active Video Gaming Intervention

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT05310279: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT05310279 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05310279, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

Replacing sedentary behaviors during leisure time with active video gaming (AVG) has been shown to be an enjoyable option for increasing the amount of physical activity acquired each week. This project will examine the feasibility of an AVG intervention using the GAIMplank.

Primary Outcome

Physical Activity Scale for Individuals with Physical Disabilities (PASIPD)

Interventions

  • OTHER GAIMplank

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2023-10-12
Est. Completion 2025-03-11
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT05310279 record still lists

NCT05310279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which GAIMplank is the first listed.

NCT05310279 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05310279 about?

NCT05310279 is a clinical study titled "Feasibility of An Active Video Gaming Intervention". Replacing sedentary behaviors during leisure time with active video gaming (AVG) has been shown to be an enjoyable option for increasing the amount of physical activity acquired each week. This project will examine the feasibility of an AVG intervention using the GAIMplank.

What is the current status of trial NCT05310279?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2023-10-12. Estimated completion is 2025-03-11.

What interventions are being tested in trial NCT05310279?

The interventions under investigation include: GAIMplank (OTHER).

Who is sponsoring clinical trial NCT05310279?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05310279's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05310279, the US trial registry maintained by the National Library of Medicine. NCT05310279 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.